Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke

Journal of Neuroimaging

Volumn 18, Issue 1, 2008, Pages 50-55

  Qureshi, Adnan I ^a   Hussein, Haitham M ^b   Janjua, Nazli ^b   Harris Lane, Pansy ^b   Ezzeddine, Mustapha A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

Clinical trial; Computed tomographic scan; Eptifibatide; Ischemic stroke; Platelet inhibitors; Reteplase

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; RETEPLASE; TIROFIBAN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RECANALIZATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PEPTIDES; PLATELET AGGREGATION INHIBITORS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 38049007569     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00185.x     Document Type: Article

References (34)

1. The global use of strategies to open occluded coronary arteries (GUSTO III) investigators. N Engl J Med 1997 337 : 1118 1123.
2. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I-Pathophysiological and pharmacological features. Neurosurgery 2000 46 : 1344 1359.
3. Anonymous. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation 2000 101 : 2788 2794.
4. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999 99 : 2720 2732.
5. Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 2000 36 : 1489 1496.
6. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001 357 : 1905 1914.
7. Goa KL, Noble S. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs 1999 57 : 439 462.
8. Ohman EM, Kleiman NS, Gacioch G, et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation 1997 18 95 : 846 854.
9. Giugliano RP, Roe MT, Harrington RA, et al. INTEGRITI Investigators. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol 2003 16 41 : 1251 1260.
10. Qureshi AI, Ali Z, Suri MF, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001 49 : 41 48 discussion 48-50.
11. Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002 51 : 1319 1327.
12. Adams HP Jr., Adams RJ, Brott T, et al. Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003 34 : 1056 1083.
13. Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002 50 : 1405 1414.
14. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004 25 : 322 328.
15. Qureshi AI. Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 2004 363 : 804 813.
16. Mohammad Y, Xavier AR, Christoforidis G, Bourekas E, Slivka A. Qureshi grading scheme for angiographic occlusions strongly correlates with the initial severity and in-hospital outcome of acute ischemic stroke. J Neuroimaging 2004 14 : 235 241.
17. Rankin J. Cerebral vascular accidents in patients over the age of 60. Ii. Prognosis. Scott Med J 1957 2 : 200 215.
18. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005 36 : 880 890.
19. Mitsias PD, Lu M, Morris D, et al. Treatment of acute supratentorial ischemic stroke with abciximab is safe and may result in early neurological improvement. A preliminary report. Cerebrovasc Dis 2004 18 : 249 250.
20. Abou-Chebl A, Bajzer CT, Krieger DW, Furlan AJ, Yadav JS. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 2005 36 : 2286 2288.
21. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke. An open-label, dose ranging, phase I study. Neurosurgery 2006 59 : 789 796.
22. Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005 36 : 1160 1165.
23. Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002 13 : 769 774.
24. Scarborough RM, Naughton MA, Teng W, et al. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 1993 268 : 1066 1073.
25. Scarborough RM, Rose JW, Hsu MA, et al. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem 1991 266 : 9359 9362.
26. Tcheng JE, Harrington RA, Kottke-Marchant K, et al. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. Circulation 1995 91 : 2151 2157.
27. Qureshi AI, Suri MF, Ali Z, et al. Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke A preliminary feasibility and safety study in a non-human primate model. Neuroradiology 2005 47 : 845 854.
28. Shuaib A, Yang Y, Nakada MT, Li Q, Yang T. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab′) 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy. J Cereb Blood Flow Metab 2002 22 : 215 222.
29. Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D. Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases. Stroke 2005 36 : 2154 2158.
30. Qureshi AI, Ali Z, Suri MF, et al. Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement. Neurosurgery 2001 48 : 998 1004.
31. Qureshi AI, Siddiqui AM, Hanel RA, et al. Safety of high-dose intravenous eptifibatide as an adjunct to internal carotid artery angioplasty and stent placement: a prospective registry. Neurosurgery 2004 54 : 307 316.
32. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002 33 : 1916 1919.
33. Qureshi AI, Suri MF, Ali Z, et al. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab. Neurosurgery 2002 50 : 466 473.
34. ® (abciximab) for acute ischemic stroke. http://www.centocor.com/news/news_100405.jsp